Related Experiment Video
Updated: Sep 21, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Hippocampal Atrophy in Pediatric Transplant Recipients with Human Herpesvirus 6B
Misa Miyake1, Yoshiki Kawamura1, Naoko Ishihara1
1Department of Pediatrics, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.
Insights
Human herpesvirus 6B (HHV-6B) infection in pediatric hematopoietic stem cell transplant (HSCT) recipients is linked to reduced hippocampal volume. This suggests potential neurological complications and the need for vigilant monitoring post-transplant.
Area of Science:
- Neuroscience
- Virology
- Pediatric Hematology/Oncology
Background:
- Pediatric hematopoietic stem cell transplantation (HSCT) is a critical treatment for various diseases.
- Human herpesvirus 6B (HHV-6B) is a common opportunistic infection post-HSCT.
- The impact of HHV-6B on the developing brain, particularly the hippocampus, remains incompletely understood.
Purpose of the Study:
- To investigate the association between HHV-6B infection and hippocampal volume changes in pediatric HSCT recipients.
- To determine if HHV-6B infection leads to hippocampal atrophy.
- To assess the correlation between HHV-6B infection, hippocampal volume, and neurological outcomes.
Main Methods:
- Retrospective analysis of pediatric HSCT recipients who underwent brain MRI before and after transplantation.
- Volumetric analysis of hippocampal regions using MRI data.
- Monitoring for HHV-6B infection and assessment of neurological symptoms, including encephalopathy.
Main Results:
- A significant reduction in hippocampal volume was observed in pediatric HSCT recipients with HHV-6B infection compared to those without (Right hippocampus: p=0.007; Left hippocampus: p=0.003).
- Four out of eight patients with HHV-6B infection showed a marked reduction in hippocampal volume (ratio < 0.90).
- Encephalopathy was more prevalent in patients with HHV-6B infection.
Conclusions:
- HHV-6B infection is associated with hippocampal volume reduction in pediatric HSCT recipients.
- These findings highlight a potential neurotoxic effect of HHV-6B on the hippocampus.
- Neurological surveillance is recommended for pediatric HSCT recipients diagnosed with HHV-6B infection.
Abstract:
The aim of this study was to determine whether human herpesvirus 6B (HHV-6B) infection can impair the hippocampus in pediatric hematopoietic stem cell transplant (HSCT) recipients. Study subjects were pediatric HSCT recipients monitored for HHV-6B infection who underwent brain MRI before and after transplantation. Volumetric analysis of the hippocampus was performed. Of the 107 patients that received HSCT at Nagoya University Hospital Between July 2008 and April 2014, 20 were eligible for volumetric analysis. Eight patients had HHV-6B infection, of whom two had encephalopathy at the time of HHV-6B infection. None of the 12 patients without HHV-6B infection had encephalopathy. The median ratio of the right hippocampal volume from before to after transplantation was 0.93 in patients with HHV-6B infection and 1.02 in without HHV-6B infection (p = 0.007). The median ratio of the left hippocampal volume ratio in patients with and without HHV-6B infection was 0.92 and 1.00, respectively (p = 0.003). Among the eight patients with HHV-6B infection, four had a marked reduction in hippocampal volume (volume ratio < 0.90). Only one of these patients had neurological symptoms at the time of HHV-6B infection. The reduction in the hippocampal volume ratio was higher in pediatric HSCT recipients with HHV-6B infection than those without viral infection. Neurological follow-up may be required for pediatric HSCT recipients with HHV-6B infection.
More Related Videos
09:54Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
05:00Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
Published on: November 11, 2022
Related Concept Videos
Herpes
Cytomegalovirus Disease
Genital Herpes